![Susan Langer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Langer
Directeur/Membre du Conseil chez
BIOGEN INC.
Profil
Susan Langer is currently an Independent Director at Biogen, Inc. since 2023.
She is a Director at Guava Partners LLC since 2021.
She serves as a Director at NextRNA Therapeutics, Inc. since 2021.
She holds the position of President & Chief Business Officer at Soufflé Therapeutics, Inc. since 2021.
She is a Venture Partner at Old Silver VC LLC.
Formerly, Ms. Langer was President at Kojin Therapeutics, Inc. from 2020 to 2021.
She was Chief Business Officer at Paratus Sciences Corp.
from 2021 to 2023.
She was Head-Corporate Strategy at Biogen, Inc. from 2013 to 2019.
Ms. Langer completed undergraduate studies at Cornell University.
Postes actifs de Susan Langer
| Sociétés | Poste | Début |
|---|---|---|
| BIOGEN INC. | Directeur/Membre du Conseil | 26/06/2023 |
NextRNA Therapeutics, Inc.
 NextRNA Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology and drug development services | Directeur/Membre du Conseil | 01/04/2021 |
Old Silver VC LLC
 Old Silver VC LLC Investment ManagersFinance Old Silver VC invests in companies located in the United States. The firm focuses on companies operating in the field of healthcare and material sciences. It provides financing for seed and early stage capital requirements. | Private Equity Investor | - |
Soufflé Therapeutics, Inc.
 Soufflé Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics | President | 01/01/2021 |
Anciens postes connus de Susan Langer
| Sociétés | Poste | Fin |
|---|---|---|
Paratus Sciences Corp.
 Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Corporate Officer/Principal | 01/01/2023 |
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Operates as a small-molecule therapeutics company which develops therapeutics for cancer, fibrosis, ischemia and immune modulation | President | 01/01/2021 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2019 |
Formation de Susan Langer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Operates as a small-molecule therapeutics company which develops therapeutics for cancer, fibrosis, ischemia and immune modulation | Health Technology |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology and drug development services | Health Technology |
Old Silver VC LLC
Old Silver VC LLC Investment ManagersFinance Old Silver VC invests in companies located in the United States. The firm focuses on companies operating in the field of healthcare and material sciences. It provides financing for seed and early stage capital requirements. | Finance |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Soufflé Therapeutics, Inc.
Soufflé Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics | Health Technology |
